Creating tools to improve the design of alcohol treatment trials
Toward a Generalized Framework and Flexible Software Environment for Power Analysis of Alcohol Treatment Randomized Controlled Trials
This study is creating an easy-to-use software tool to help researchers plan better alcohol treatment trials, which could lead to more effective treatments for people struggling with alcohol use disorder.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Missouri-Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project ID | NIH-10733319 on NIH RePORTER |
What this research studies
This research aims to enhance the reliability of alcohol treatment trials by developing a user-friendly software tool for statistical power analysis. It addresses the common issue of inadequate sample size determination in complex statistical models used in alcohol research. By providing accessible methods for researchers, the project seeks to ensure that trials are optimally designed, leading to more conclusive results. Patients may benefit indirectly as improved trial designs could lead to more effective treatments for alcohol use disorder.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research are individuals involved in alcohol treatment trials or those affected by alcohol use disorder.
Not a fit: Patients who are not involved in alcohol treatment trials or do not have alcohol use disorder may not receive any direct benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and reliable treatments for alcohol use disorder.
How similar studies have performed: While the approach of developing software for power analysis is innovative, similar methodologies have shown promise in enhancing the design of clinical trials in other areas.
Where this research is happening
Columbia, United States
- University of Missouri-Columbia — Columbia, United States (Active)
Researchers
- Principal investigator: Lane, Sean P — University of Missouri-Columbia
- Study coordinator: Lane, Sean P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.